GLABF (Gemina Laboratories) Net Margin %: 0.00% (As of Oct. 2025)


What is Gemina Laboratories Net Margin %?

Gemina Laboratories GLABF -27.59% Net Margin % is 0.00% as of Oct. 2025. The stock has 2 warning signs investors should review.

Net margin is calculated as Net Income divided by its Revenue. Gemina Laboratories's Net Income for the three months ended in Oct. 2025 was $-0.24 Mil. Gemina Laboratories's Revenue for the three months ended in Oct. 2025 was $0.00 Mil. Therefore, Gemina Laboratories's net margin for the quarter that ended in Oct. 2025 was 0.00%.

The historical rank and industry rank for Gemina Laboratories's Net Margin % or its related term are showing as below:

GLABF' s Net Margin % Range Over the Past 10 Years
Min: -26636.36   Med: 0   Max: 0
Current: -26636.36

GLABF's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -88.815 vs GLABF: -26636.36

Gemina Laboratories  (OTCPK:GLABF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Gemina Laboratories Net Margin % Related Terms

Gemina Laboratories Net Margin % Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Net Margin % Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Net Margin %
0.00 0.00 0.00 0.00 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -6,800.00 0.00 0.00

GLABF vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Gemina Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Net Margin % falls into.


Gemina Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Gemina Laboratories's Net Margin for the fiscal year that ended in Jan. 2025 is calculated as

Net Margin=Net Income (A: Jan. 2025 )/Revenue (A: Jan. 2025 )
=-2.831/0
= %

Gemina Laboratories's Net Margin for the quarter that ended in Oct. 2025 is calculated as

Net Margin=Net Income (Q: Oct. 2025 )/Revenue (Q: Oct. 2025 )
=-0.239/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Gemina Laboratories (GLABF) has a Net Margin % of 0.00% as of Oct. 2025. Net margin is the ratio of total net income to net sales. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Net Margin % too high?
Gemina Laboratories' current Net Margin % is 0.00%.
How does Gemina Laboratories' Net Margin % compare to VRTX and REGN?
Gemina Laboratories' Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Net Margin % is 0.00% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.